4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      PACS-2 deficiency in tubular cells aggravates lipid-related kidney injury in diabetic kidney disease

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Lipid accumulation in tubular cells plays a key role in diabetic kidney disease (DKD). Targeting lipid metabolism disorders has clinical value in delaying the progression of DKD, but the precise mechanism by which molecules mediate lipid-related kidney injury remains unclear. Phosphofurin acidic cluster sorting protein 2 (PACS-2) is a multifunctional sorting protein that plays a role in lipid metabolism. This study determined the role of PACS-2 in lipid-related kidney injury in DKD.

          Methods

          Diabetes was induced by a high-fat diet combined with intraperitoneal injections of streptozotocin (HFD/STZ) in proximal tubule-specific knockout of Pacs-2 mice ( PT- Pacs-2 −/− mice) and the control mice ( Pacs-2 fl/fl mice). Transcriptomic analysis was performed between Pacs-2 fl/fl mice and PT- Pacs-2 −/− mice.

          Results

          Diabetic PT- Pacs-2 −/− mice developed more severe tubule injury and proteinuria compared to diabetic Pacs-2 fl/fl mice, which accompanied with increasing lipid synthesis, uptake and decreasing cholesterol efflux as well as lipid accumulation in tubules of the kidney. Furthermore, transcriptome analysis showed that the mRNA level of sterol O-acyltransferase 1 ( Soat1) was up-regulated in the kidney of control PT- Pacs-2 −/− mice. Transfection of HK2 cells with PACS-2 siRNA under high glucose plus palmitic acid (HGPA) condition aggravated lipid deposition and increased the expression of SOAT1 and sterol regulatory element-binding proteins (SREBPs), while the effect was blocked partially in that of co-transfection of SOAT1 siRNA.

          Conclusions

          PACS-2 has a protective role against lipid-related kidney injury in DKD through SOAT1/SREBPs signaling.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s10020-022-00545-x.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development.

          Renal fibrosis is the histological manifestation of a progressive, usually irreversible process causing chronic and end-stage kidney disease. We performed genome-wide transcriptome studies of a large cohort (n = 95) of normal and fibrotic human kidney tubule samples followed by systems and network analyses and identified inflammation and metabolism as the top dysregulated pathways in the diseased kidneys. In particular, we found that humans and mouse models with tubulointerstitial fibrosis had lower expression of key enzymes and regulators of fatty acid oxidation (FAO) and higher intracellular lipid deposition compared to controls. In vitro experiments indicated that inhibition of FAO in tubule epithelial cells caused ATP depletion, cell death, dedifferentiation and intracellular lipid deposition, phenotypes observed in fibrosis. In contrast, restoring fatty acid metabolism by genetic or pharmacological methods protected mice from tubulointerstitial fibrosis. Our results raise the possibility that correcting the metabolic defect in FAO may be useful for preventing and treating chronic kidney disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            SREBP-regulated lipid metabolism: convergent physiology — divergent pathophysiology

            In addition to controlling cellular lipid metabolism and homeostasis, sterol regulatory element-binding proteins (SREBPs) act as nodes of convergence and divergence within myriad physiological and pathophysiological processes. Here, Shimano and Sato provide a comprehensive overview of the role of SREBPs in health and disease, at the cell, organ and organism levels.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Triglyceride accumulation protects against fatty acid-induced lipotoxicity.

              Excess lipid accumulation in non-adipose tissues is associated with insulin resistance, pancreatic beta-cell apoptosis and heart failure. Here, we demonstrate in cultured cells that the relative toxicity of two common dietary long chain fatty acids is related to channeling of these lipids to distinct cellular metabolic fates. Oleic acid supplementation leads to triglyceride accumulation and is well tolerated, whereas excess palmitic acid is poorly incorporated into triglyceride and causes apoptosis. Unsaturated fatty acids rescue palmitate-induced apoptosis by channeling palmitate into triglyceride pools and away from pathways leading to apoptosis. Moreover, in the setting of impaired triglyceride synthesis, oleate induces lipotoxicity. Our findings support a model of cellular lipid metabolism in which unsaturated fatty acids serve a protective function against lipotoxicity though promotion of triglyceride accumulation.
                Bookmark

                Author and article information

                Contributors
                sunlin@csu.edu.cn
                Journal
                Mol Med
                Mol Med
                Molecular Medicine
                BioMed Central (London )
                1076-1551
                1528-3658
                23 September 2022
                23 September 2022
                2022
                : 28
                : 117
                Affiliations
                GRID grid.452708.c, ISNI 0000 0004 1803 0208, Department of Nephrology, Hunan Key Laboratory of Kidney Disease and Blood Purification, , The Second Xiangya Hospital, Central South University, ; No.139 Renmin Middle Road, Changsha, 410011 Hunan China
                Author information
                http://orcid.org/0000-0002-4544-0822
                Article
                545
                10.1186/s10020-022-00545-x
                9502582
                36138342
                0a9f7387-26d6-4d5d-9f69-34a0f57fc775
                © The Author(s) 2022

                Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 13 April 2022
                : 9 September 2022
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/501100001809, National Natural Science Foundation of China;
                Award ID: 81730018
                Award Recipient :
                Categories
                Research Article
                Custom metadata
                © The Author(s) 2022

                diabetic kidney disease,pacs-2,soat1,srebp
                diabetic kidney disease, pacs-2, soat1, srebp

                Comments

                Comment on this article